Osteoarthritis Medications Market

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Osteoarthritis Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 NSAIDs
        1.2.3 Corticosteroids
        1.2.4 Hyaluronic Acid Injection
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Osteoarthritis Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Osteoarthritis Medications Market Perspective (2017-2028)
    2.2 Osteoarthritis Medications Growth Trends by Region
        2.2.1 Osteoarthritis Medications Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Osteoarthritis Medications Historic Market Size by Region (2017-2022)
        2.2.3 Osteoarthritis Medications Forecasted Market Size by Region (2023-2028)
    2.3 Osteoarthritis Medications Market Dynamics
        2.3.1 Osteoarthritis Medications Industry Trends
        2.3.2 Osteoarthritis Medications Market Drivers
        2.3.3 Osteoarthritis Medications Market Challenges
        2.3.4 Osteoarthritis Medications Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Osteoarthritis Medications Players by Revenue
        3.1.1 Global Top Osteoarthritis Medications Players by Revenue (2017-2022)
        3.1.2 Global Osteoarthritis Medications Revenue Market Share by Players (2017-2022)
    3.2 Global Osteoarthritis Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Osteoarthritis Medications Revenue
    3.4 Global Osteoarthritis Medications Market Concentration Ratio
        3.4.1 Global Osteoarthritis Medications Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Osteoarthritis Medications Revenue in 2021
    3.5 Osteoarthritis Medications Key Players Head office and Area Served
    3.6 Key Players Osteoarthritis Medications Product Solution and Service
    3.7 Date of Enter into Osteoarthritis Medications Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Osteoarthritis Medications Breakdown Data by Type
    4.1 Global Osteoarthritis Medications Historic Market Size by Type (2017-2022)
    4.2 Global Osteoarthritis Medications Forecasted Market Size by Type (2023-2028)
5 Osteoarthritis Medications Breakdown Data by Application
    5.1 Global Osteoarthritis Medications Historic Market Size by Application (2017-2022)
    5.2 Global Osteoarthritis Medications Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Osteoarthritis Medications Market Size (2017-2028)
    6.2 North America Osteoarthritis Medications Market Size by Type
        6.2.1 North America Osteoarthritis Medications Market Size by Type (2017-2022)
        6.2.2 North America Osteoarthritis Medications Market Size by Type (2023-2028)
        6.2.3 North America Osteoarthritis Medications Market Share by Type (2017-2028)
    6.3 North America Osteoarthritis Medications Market Size by Application
        6.3.1 North America Osteoarthritis Medications Market Size by Application (2017-2022)
        6.3.2 North America Osteoarthritis Medications Market Size by Application (2023-2028)
        6.3.3 North America Osteoarthritis Medications Market Share by Application (2017-2028)
    6.4 North America Osteoarthritis Medications Market Size by Country
        6.4.1 North America Osteoarthritis Medications Market Size by Country (2017-2022)
        6.4.2 North America Osteoarthritis Medications Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Osteoarthritis Medications Market Size (2017-2028)
    7.2 Europe Osteoarthritis Medications Market Size by Type
        7.2.1 Europe Osteoarthritis Medications Market Size by Type (2017-2022)
        7.2.2 Europe Osteoarthritis Medications Market Size by Type (2023-2028)
        7.2.3 Europe Osteoarthritis Medications Market Share by Type (2017-2028)
    7.3 Europe Osteoarthritis Medications Market Size by Application
        7.3.1 Europe Osteoarthritis Medications Market Size by Application (2017-2022)
        7.3.2 Europe Osteoarthritis Medications Market Size by Application (2023-2028)
        7.3.3 Europe Osteoarthritis Medications Market Share by Application (2017-2028)
    7.4 Europe Osteoarthritis Medications Market Size by Country
        7.4.1 Europe Osteoarthritis Medications Market Size by Country (2017-2022)
        7.4.2 Europe Osteoarthritis Medications Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Osteoarthritis Medications Market Size (2017-2028)
    8.2 Asia-Pacific Osteoarthritis Medications Market Size by Type
        8.2.1 Asia-Pacific Osteoarthritis Medications Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Osteoarthritis Medications Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Osteoarthritis Medications Market Share by Type (2017-2028)
    8.3 Asia-Pacific Osteoarthritis Medications Market Size by Application
        8.3.1 Asia-Pacific Osteoarthritis Medications Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Osteoarthritis Medications Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Osteoarthritis Medications Market Share by Application (2017-2028)
    8.4 Asia-Pacific Osteoarthritis Medications Market Size by Region
        8.4.1 Asia-Pacific Osteoarthritis Medications Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Osteoarthritis Medications Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Osteoarthritis Medications Market Size (2017-2028)
    9.2 Latin America Osteoarthritis Medications Market Size by Type
        9.2.1 Latin America Osteoarthritis Medications Market Size by Type (2017-2022)
        9.2.2 Latin America Osteoarthritis Medications Market Size by Type (2023-2028)
        9.2.3 Latin America Osteoarthritis Medications Market Share by Type (2017-2028)
    9.3 Latin America Osteoarthritis Medications Market Size by Application
        9.3.1 Latin America Osteoarthritis Medications Market Size by Application (2017-2022)
        9.3.2 Latin America Osteoarthritis Medications Market Size by Application (2023-2028)
        9.3.3 Latin America Osteoarthritis Medications Market Share by Application (2017-2028)
    9.4 Latin America Osteoarthritis Medications Market Size by Country
        9.4.1 Latin America Osteoarthritis Medications Market Size by Country (2017-2022)
        9.4.2 Latin America Osteoarthritis Medications Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Osteoarthritis Medications Market Size (2017-2028)
    10.2 Middle East & Africa Osteoarthritis Medications Market Size by Type
        10.2.1 Middle East & Africa Osteoarthritis Medications Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Osteoarthritis Medications Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Osteoarthritis Medications Market Share by Type (2017-2028)
    10.3 Middle East & Africa Osteoarthritis Medications Market Size by Application
        10.3.1 Middle East & Africa Osteoarthritis Medications Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Osteoarthritis Medications Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Osteoarthritis Medications Market Share by Application (2017-2028)
    10.4 Middle East & Africa Osteoarthritis Medications Market Size by Country
        10.4.1 Middle East & Africa Osteoarthritis Medications Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Osteoarthritis Medications Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Osteoarthritis Medications Introduction
        11.1.4 Pfizer Revenue in Osteoarthritis Medications Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Details
        11.2.2 Johnson & Johnson Business Overview
        11.2.3 Johnson & Johnson Osteoarthritis Medications Introduction
        11.2.4 Johnson & Johnson Revenue in Osteoarthritis Medications Business (2017-2022)
        11.2.5 Johnson & Johnson Recent Developments
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Osteoarthritis Medications Introduction
        11.3.4 GlaxoSmithKline Revenue in Osteoarthritis Medications Business (2017-2022)
        11.3.5 GlaxoSmithKline Recent Developments
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Osteoarthritis Medications Introduction
        11.4.4 Novartis Revenue in Osteoarthritis Medications Business (2017-2022)
        11.4.5 Novartis Recent Developments
    11.5 Bayer
        11.5.1 Bayer Company Details
        11.5.2 Bayer Business Overview
        11.5.3 Bayer Osteoarthritis Medications Introduction
        11.5.4 Bayer Revenue in Osteoarthritis Medications Business (2017-2022)
        11.5.5 Bayer Recent Developments
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Details
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly Osteoarthritis Medications Introduction
        11.6.4 Eli Lilly Revenue in Osteoarthritis Medications Business (2017-2022)
        11.6.5 Eli Lilly Recent Developments
    11.7 Sanofi
        11.7.1 Sanofi Company Details
        11.7.2 Sanofi Business Overview
        11.7.3 Sanofi Osteoarthritis Medications Introduction
        11.7.4 Sanofi Revenue in Osteoarthritis Medications Business (2017-2022)
        11.7.5 Sanofi Recent Developments
    11.8 Horizon Pharma
        11.8.1 Horizon Pharma Company Details
        11.8.2 Horizon Pharma Business Overview
        11.8.3 Horizon Pharma Osteoarthritis Medications Introduction
        11.8.4 Horizon Pharma Revenue in Osteoarthritis Medications Business (2017-2022)
        11.8.5 Horizon Pharma Recent Developments
    11.9 Abbott
        11.9.1 Abbott Company Details
        11.9.2 Abbott Business Overview
        11.9.3 Abbott Osteoarthritis Medications Introduction
        11.9.4 Abbott Revenue in Osteoarthritis Medications Business (2017-2022)
        11.9.5 Abbott Recent Developments
    11.10 Mylan
        11.10.1 Mylan Company Details
        11.10.2 Mylan Business Overview
        11.10.3 Mylan Osteoarthritis Medications Introduction
        11.10.4 Mylan Revenue in Osteoarthritis Medications Business (2017-2022)
        11.10.5 Mylan Recent Developments
    11.11 Daiichi Sankyo
        11.11.1 Daiichi Sankyo Company Details
        11.11.2 Daiichi Sankyo Business Overview
        11.11.3 Daiichi Sankyo Osteoarthritis Medications Introduction
        11.11.4 Daiichi Sankyo Revenue in Osteoarthritis Medications Business (2017-2022)
        11.11.5 Daiichi Sankyo Recent Developments
    11.12 TEVA
        11.12.1 TEVA Company Details
        11.12.2 TEVA Business Overview
        11.12.3 TEVA Osteoarthritis Medications Introduction
        11.12.4 TEVA Revenue in Osteoarthritis Medications Business (2017-2022)
        11.12.5 TEVA Recent Developments
    11.13 Almatica Pharma
        11.13.1 Almatica Pharma Company Details
        11.13.2 Almatica Pharma Business Overview
        11.13.3 Almatica Pharma Osteoarthritis Medications Introduction
        11.13.4 Almatica Pharma Revenue in Osteoarthritis Medications Business (2017-2022)
        11.13.5 Almatica Pharma Recent Developments
    11.14 Astellas Pharma
        11.14.1 Astellas Pharma Company Details
        11.14.2 Astellas Pharma Business Overview
        11.14.3 Astellas Pharma Osteoarthritis Medications Introduction
        11.14.4 Astellas Pharma Revenue in Osteoarthritis Medications Business (2017-2022)
        11.14.5 Astellas Pharma Recent Developments
    11.15 Tide Pharmaceutical
        11.15.1 Tide Pharmaceutical Company Details
        11.15.2 Tide Pharmaceutical Business Overview
        11.15.3 Tide Pharmaceutical Osteoarthritis Medications Introduction
        11.15.4 Tide Pharmaceutical Revenue in Osteoarthritis Medications Business (2017-2022)
        11.15.5 Tide Pharmaceutical Recent Developments
    11.16 Iroko Pharmaceuticals
        11.16.1 Iroko Pharmaceuticals Company Details
        11.16.2 Iroko Pharmaceuticals Business Overview
        11.16.3 Iroko Pharmaceuticals Osteoarthritis Medications Introduction
        11.16.4 Iroko Pharmaceuticals Revenue in Osteoarthritis Medications Business (2017-2022)
        11.16.5 Iroko Pharmaceuticals Recent Developments
    11.17 Hengrui Pharmaceutical
        11.17.1 Hengrui Pharmaceutical Company Details
        11.17.2 Hengrui Pharmaceutical Business Overview
        11.17.3 Hengrui Pharmaceutical Osteoarthritis Medications Introduction
        11.17.4 Hengrui Pharmaceutical Revenue in Osteoarthritis Medications Business (2017-2022)
        11.17.5 Hengrui Pharmaceutical Recent Developments
    11.18 Abiogen Pharma
        11.18.1 Abiogen Pharma Company Details
        11.18.2 Abiogen Pharma Business Overview
        11.18.3 Abiogen Pharma Osteoarthritis Medications Introduction
        11.18.4 Abiogen Pharma Revenue in Osteoarthritis Medications Business (2017-2022)
        11.18.5 Abiogen Pharma Recent Developments
    11.19 Flexion Therapeutics
        11.19.1 Flexion Therapeutics Company Details
        11.19.2 Flexion Therapeutics Business Overview
        11.19.3 Flexion Therapeutics Osteoarthritis Medications Introduction
        11.19.4 Flexion Therapeutics Revenue in Osteoarthritis Medications Business (2017-2022)
        11.19.5 Flexion Therapeutics Recent Developments
    11.20 Anika Therapeutics
        11.20.1 Anika Therapeutics Company Details
        11.20.2 Anika Therapeutics Business Overview
        11.20.3 Anika Therapeutics Osteoarthritis Medications Introduction
        11.20.4 Anika Therapeutics Revenue in Osteoarthritis Medications Business (2017-2022)
        11.20.5 Anika Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Osteoarthritis Medications Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of NSAIDs
    Table 3. Key Players of Corticosteroids
    Table 4. Key Players of Hyaluronic Acid Injection
    Table 5. Key Players of Others
    Table 6. Global Osteoarthritis Medications Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Osteoarthritis Medications Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Osteoarthritis Medications Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Osteoarthritis Medications Market Share by Region (2017-2022)
    Table 10. Global Osteoarthritis Medications Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Osteoarthritis Medications Market Share by Region (2023-2028)
    Table 12. Osteoarthritis Medications Market Trends
    Table 13. Osteoarthritis Medications Market Drivers
    Table 14. Osteoarthritis Medications Market Challenges
    Table 15. Osteoarthritis Medications Market Restraints
    Table 16. Global Osteoarthritis Medications Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Osteoarthritis Medications Revenue Share by Players (2017-2022)
    Table 18. Global Top Osteoarthritis Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2021)
    Table 19. Ranking of Global Top Osteoarthritis Medications Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Osteoarthritis Medications Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Osteoarthritis Medications Product Solution and Service
    Table 23. Date of Enter into Osteoarthritis Medications Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Osteoarthritis Medications Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Osteoarthritis Medications Revenue Market Share by Type (2017-2022)
    Table 27. Global Osteoarthritis Medications Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Osteoarthritis Medications Revenue Market Share by Type (2023-2028)
    Table 29. Global Osteoarthritis Medications Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Osteoarthritis Medications Revenue Share by Application (2017-2022)
    Table 31. Global Osteoarthritis Medications Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Osteoarthritis Medications Revenue Share by Application (2023-2028)
    Table 33. North America Osteoarthritis Medications Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Osteoarthritis Medications Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Osteoarthritis Medications Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Osteoarthritis Medications Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Osteoarthritis Medications Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Osteoarthritis Medications Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Osteoarthritis Medications Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Osteoarthritis Medications Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Osteoarthritis Medications Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Osteoarthritis Medications Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Osteoarthritis Medications Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Osteoarthritis Medications Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Osteoarthritis Medications Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Osteoarthritis Medications Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Osteoarthritis Medications Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Osteoarthritis Medications Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Osteoarthritis Medications Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Osteoarthritis Medications Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Osteoarthritis Medications Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Osteoarthritis Medications Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Osteoarthritis Medications Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Osteoarthritis Medications Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Osteoarthritis Medications Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Osteoarthritis Medications Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Osteoarthritis Medications Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Osteoarthritis Medications Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Osteoarthritis Medications Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Osteoarthritis Medications Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Osteoarthritis Medications Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Osteoarthritis Medications Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Pfizer Company Details
    Table 64. Pfizer Business Overview
    Table 65. Pfizer Osteoarthritis Medications Product
    Table 66. Pfizer Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 67. Pfizer Recent Developments
    Table 68. Johnson & Johnson Company Details
    Table 69. Johnson & Johnson Business Overview
    Table 70. Johnson & Johnson Osteoarthritis Medications Product
    Table 71. Johnson & Johnson Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 72. Johnson & Johnson Recent Developments
    Table 73. GlaxoSmithKline Company Details
    Table 74. GlaxoSmithKline Business Overview
    Table 75. GlaxoSmithKline Osteoarthritis Medications Product
    Table 76. GlaxoSmithKline Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 77. GlaxoSmithKline Recent Developments
    Table 78. Novartis Company Details
    Table 79. Novartis Business Overview
    Table 80. Novartis Osteoarthritis Medications Product
    Table 81. Novartis Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 82. Novartis Recent Developments
    Table 83. Bayer Company Details
    Table 84. Bayer Business Overview
    Table 85. Bayer Osteoarthritis Medications Product
    Table 86. Bayer Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 87. Bayer Recent Developments
    Table 88. Eli Lilly Company Details
    Table 89. Eli Lilly Business Overview
    Table 90. Eli Lilly Osteoarthritis Medications Product
    Table 91. Eli Lilly Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 92. Eli Lilly Recent Developments
    Table 93. Sanofi Company Details
    Table 94. Sanofi Business Overview
    Table 95. Sanofi Osteoarthritis Medications Product
    Table 96. Sanofi Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 97. Sanofi Recent Developments
    Table 98. Horizon Pharma Company Details
    Table 99. Horizon Pharma Business Overview
    Table 100. Horizon Pharma Osteoarthritis Medications Product
    Table 101. Horizon Pharma Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 102. Horizon Pharma Recent Developments
    Table 103. Abbott Company Details
    Table 104. Abbott Business Overview
    Table 105. Abbott Osteoarthritis Medications Product
    Table 106. Abbott Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 107. Abbott Recent Developments
    Table 108. Mylan Company Details
    Table 109. Mylan Business Overview
    Table 110. Mylan Osteoarthritis Medications Product
    Table 111. Mylan Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 112. Mylan Recent Developments
    Table 113. Daiichi Sankyo Company Details
    Table 114. Daiichi Sankyo Business Overview
    Table 115. Daiichi Sankyo Osteoarthritis Medications Product
    Table 116. Daiichi Sankyo Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 117. Daiichi Sankyo Recent Developments
    Table 118. TEVA Company Details
    Table 119. TEVA Business Overview
    Table 120. TEVA Osteoarthritis Medications Product
    Table 121. TEVA Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 122. TEVA Recent Developments
    Table 123. Almatica Pharma Company Details
    Table 124. Almatica Pharma Business Overview
    Table 125. Almatica Pharma Osteoarthritis Medications Product
    Table 126. Almatica Pharma Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 127. Almatica Pharma Recent Developments
    Table 128. Astellas Pharma Company Details
    Table 129. Astellas Pharma Business Overview
    Table 130. Astellas Pharma Osteoarthritis Medications Product
    Table 131. Astellas Pharma Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 132. Astellas Pharma Recent Developments
    Table 133. Tide Pharmaceutical Company Details
    Table 134. Tide Pharmaceutical Business Overview
    Table 135. Tide Pharmaceutical Osteoarthritis Medications Product
    Table 136. Tide Pharmaceutical Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 137. Tide Pharmaceutical Recent Developments
    Table 138. Iroko Pharmaceuticals Company Details
    Table 139. Iroko Pharmaceuticals Business Overview
    Table 140. Iroko Pharmaceuticals Osteoarthritis Medications Product
    Table 141. Iroko Pharmaceuticals Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 142. Iroko Pharmaceuticals Recent Developments
    Table 143. Hengrui Pharmaceutical Company Details
    Table 144. Hengrui Pharmaceutical Business Overview
    Table 145. Hengrui Pharmaceutical Osteoarthritis Medications Product
    Table 146. Hengrui Pharmaceutical Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 147. Hengrui Pharmaceutical Recent Developments
    Table 148. Abiogen Pharma Company Details
    Table 149. Abiogen Pharma Business Overview
    Table 150. Abiogen Pharma Osteoarthritis Medications Product
    Table 151. Abiogen Pharma Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 152. Abiogen Pharma Recent Developments
    Table 153. Flexion Therapeutics Company Details
    Table 154. Flexion Therapeutics Business Overview
    Table 155. Flexion Therapeutics Osteoarthritis Medications Product
    Table 156. Flexion Therapeutics Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 157. Flexion Therapeutics Recent Developments
    Table 158. Anika Therapeutics Company Details
    Table 159. Anika Therapeutics Business Overview
    Table 160. Anika Therapeutics Osteoarthritis Medications Product
    Table 161. Anika Therapeutics Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 162. Anika Therapeutics Recent Developments
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Osteoarthritis Medications Market Share by Type: 2021 VS 2028
    Figure 2. NSAIDs Features
    Figure 3. Corticosteroids Features
    Figure 4. Hyaluronic Acid Injection Features
    Figure 5. Others Features
    Figure 6. Global Osteoarthritis Medications Market Share by Application: 2021 VS 2028
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Retail Pharmacies Case Studies
    Figure 9. Online Pharmacies Case Studies
    Figure 10. Osteoarthritis Medications Report Years Considered
    Figure 11. Global Osteoarthritis Medications Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Osteoarthritis Medications Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Osteoarthritis Medications Market Share by Region: 2021 VS 2028
    Figure 14. Global Osteoarthritis Medications Market Share by Players in 2021
    Figure 15. Global Top Osteoarthritis Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Osteoarthritis Medications Revenue in 2021
    Figure 17. North America Osteoarthritis Medications Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Osteoarthritis Medications Market Size Market Share by Type (2017-2028)
    Figure 19. North America Osteoarthritis Medications Market Size Market Share by Application (2017-2028)
    Figure 20. North America Osteoarthritis Medications Market Size Share by Country (2017-2028)
    Figure 21. United States Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Osteoarthritis Medications Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Osteoarthritis Medications Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Osteoarthritis Medications Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Osteoarthritis Medications Market Size Share by Country (2017-2028)
    Figure 27. Germany Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Osteoarthritis Medications Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Osteoarthritis Medications Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Osteoarthritis Medications Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Osteoarthritis Medications Market Size Share by Region (2017-2028)
    Figure 37. China Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Osteoarthritis Medications Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Osteoarthritis Medications Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Osteoarthritis Medications Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Osteoarthritis Medications Market Size Share by Country (2017-2028)
    Figure 47. Mexico Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Osteoarthritis Medications Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Osteoarthritis Medications Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Osteoarthritis Medications Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Osteoarthritis Medications Market Size Share by Country (2017-2028)
    Figure 53. Turkey Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Pfizer Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 58. GlaxoSmithKline Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 60. Bayer Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 61. Eli Lilly Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 62. Sanofi Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 63. Horizon Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 64. Abbott Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 65. Mylan Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 66. Daiichi Sankyo Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 67. TEVA Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 68. Almatica Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 69. Astellas Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 70. Tide Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 71. Iroko Pharmaceuticals Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 72. Hengrui Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 73. Abiogen Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 74. Flexion Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 75. Anika Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed